Skip to main content

J65 (Morphine Sulfate Extended-Release 60 mg)

Pill with imprint J65 is Red, Capsule-shape and has been identified as Morphine Sulfate Extended-Release 60 mg. It is supplied by Amneal Pharmaceuticals LLC.

Morphine is used in the treatment of chronic pain; neonatal abstinence syndrome; pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Morphine 60 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for J65

Morphine sulfate extended-release 60 mg J65
Morphine sulfate extended-release 60 mg J65
Morphine sulfate extended-release 60 mg J65

Morphine Sulfate Extended-Release

Imprint
J65
Strength
60 mg
Color
Red
Size
19.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Narcotic analgesics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
2 - High potential for abuse
Labeler / Supplier
Amneal Pharmaceuticals LLC
National Drug Code (NDC)
00115-1280 (Discontinued)
Inactive Ingredients
hypromelloses, ethylcellulose, methacrylic acid - ethyl acrylate copolymer (1:1) type a, polyethylene glycol, diethyl phthalate, magnesium silicate, corn starch, sucrose, FD&C Red No. 40, gelatin, titanium dioxide, shellac, alcohol, isopropyl alcohol, butyl alcohol, propylene glycol, ammonia, ferrosoferric oxide, potassium hydroxide, water

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.